Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
PLYMOUTH, Minn., Dec. 8 /PRNewswire-FirstCall/ -- ev3 Inc. (NASDAQ:EVVV), a global endovascular device company, announced today that it expects...
ev3 Inc. to Acquire Approximately 29.9% of Shares Not Already Owned PLYMOUTH, Minn., and IRVINE, Calif., Nov. 14 /PRNewswire-FirstCall/ -- ev3...
- Company Significantly Narrows Net Loss With Growth in Net Sales, Higher Gross Margins and Improved Cost Control - IRVINE, Calif., Oct. 27...
Net Sales Grow by 70% Compared to Year-Ago Period PLYMOUTH, Minn., Oct. 27 /PRNewswire-FirstCall/ -- ev3 Inc. (NASDAQ:EVVV), a global...
PLYMOUTH, Minn., or IRVINE, Calif., Oct. 21 /PRNewswire-FirstCall/ -- ev3 Inc. (NASDAQ:EVVV) and its majority-owned subsidiary Micro...
Proposes Purchase of Approximately 29.8% of Shares Not Already Owned PLYMOUTH, Minn., Oct. 10 /PRNewswire-FirstCall/ -- ev3 Inc. (NASDAQ:EVVV...
IRVINE, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Micro Therapeutics, Inc. (MTI) (NASDAQ:MTIX), an endovascular medical device company focused...
Net Sales Grow to $14.1 Million, a 72% Increase Compared to Third Quarter 2004 IRVINE, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Micro...
- Joint Conference Call With ev3 Inc. Scheduled for Today at 5:00 p.m. EDT (2:00 p.m. PDT); Simultaneous Webcast at www.1mti.com - IRVINE...
Net Sales Grow by 53% Compared to Year-Ago Period PLYMOUTH, Minn., Aug. 2 /PRNewswire-FirstCall/ -- ev3 Inc. (NASDAQ:EVVV), a global endovascular...
ev3 and Micro Therapeutics to Report 2005 Second Quarter Financial Results and Host Joint Conference Call on August 2, 2005 PLYMOUTH, Minn. and...
ev3 Inc. Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular Disorder PLYMOUTH, Minn., July 21 /PRNewswire-FirstCall/ -- ev3...
Micro Therapeutics Announces FDA Approval of Onyx(R) for the Treatment of Brain Vascular Disorder IRVINE, Calif., July 21 /PRNewswire-FirstCall/...
Micro Therapeutics, Inc. Reports Sales Results for Second Quarter 2005 Net Sales Grow to $13.1 Million, a 44% Increase Compared to Second Quarter...
Micro Therapeutics Reports 50% Net Sales Increase for 2005 First Quarter - Conference Call Scheduled for Today at 1:30 p.m. PDT; Simultaneous...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관